nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—SLC15A2—Trandolapril—coronary artery disease	0.0867	0.107	CbGbCtD
Ceftazidime—SLC15A2—Perindopril—coronary artery disease	0.0793	0.0982	CbGbCtD
Ceftazidime—SLC15A1—Trandolapril—coronary artery disease	0.0747	0.0925	CbGbCtD
Ceftazidime—SLC15A1—Perindopril—coronary artery disease	0.0683	0.0846	CbGbCtD
Ceftazidime—SLC15A2—Ramipril—coronary artery disease	0.0657	0.0814	CbGbCtD
Ceftazidime—SLC15A1—Enalapril—coronary artery disease	0.0566	0.0701	CbGbCtD
Ceftazidime—SLC15A1—Lisinopril—coronary artery disease	0.0566	0.0701	CbGbCtD
Ceftazidime—SLC15A1—Ramipril—coronary artery disease	0.0566	0.0701	CbGbCtD
Ceftazidime—SLC22A5—Niacin—coronary artery disease	0.0501	0.062	CbGbCtD
Ceftazidime—SLC15A1—Captopril—coronary artery disease	0.0424	0.0525	CbGbCtD
Ceftazidime—SLC22A5—Furosemide—coronary artery disease	0.0329	0.0408	CbGbCtD
Ceftazidime—SLC22A6—Enalapril—coronary artery disease	0.0312	0.0386	CbGbCtD
Ceftazidime—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.0236	0.0293	CbGbCtD
Ceftazidime—SLC22A6—Captopril—coronary artery disease	0.0233	0.0289	CbGbCtD
Ceftazidime—SLC22A6—Pravastatin—coronary artery disease	0.0221	0.0273	CbGbCtD
Ceftazidime—SLC22A6—Furosemide—coronary artery disease	0.0188	0.0232	CbGbCtD
Ceftazidime—SLC22A6—Losartan—coronary artery disease	0.0184	0.0228	CbGbCtD
Ceftazidime—SLC22A5—Organic cation transport—SLC22A3—coronary artery disease	0.000479	0.108	CbGpPWpGaD
Ceftazidime—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—coronary artery disease	0.000325	0.0733	CbGpPWpGaD
Ceftazidime—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—coronary artery disease	0.000245	0.0553	CbGpPWpGaD
Ceftazidime—Cefdinir—MPO—coronary artery disease	0.000228	0.373	CrCbGaD
Ceftazidime—Cefaclor—MPO—coronary artery disease	0.000226	0.37	CrCbGaD
Ceftazidime—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC6A6—coronary artery disease	0.000191	0.0431	CbGpPWpGaD
Ceftazidime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC6A6—coronary artery disease	0.000177	0.04	CbGpPWpGaD
Ceftazidime—Urticaria—Niacin—coronary artery disease	0.000142	0.000756	CcSEcCtD
Ceftazidime—Nausea—Acetylsalicylic acid—coronary artery disease	0.000142	0.000755	CcSEcCtD
Ceftazidime—Pruritus—Eplerenone—coronary artery disease	0.000141	0.000753	CcSEcCtD
Ceftazidime—Body temperature increased—Niacin—coronary artery disease	0.000141	0.000752	CcSEcCtD
Ceftazidime—Abdominal pain—Niacin—coronary artery disease	0.000141	0.000752	CcSEcCtD
Ceftazidime—Dizziness—Fenofibrate—coronary artery disease	0.000141	0.00075	CcSEcCtD
Ceftazidime—Leukopenia—Ramipril—coronary artery disease	0.00014	0.000744	CcSEcCtD
Ceftazidime—Urticaria—Pravastatin—coronary artery disease	0.00014	0.000744	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Trandolapril—coronary artery disease	0.00014	0.000744	CcSEcCtD
Ceftazidime—Diarrhoea—Ezetimibe—coronary artery disease	0.00014	0.000744	CcSEcCtD
Ceftazidime—Angioedema—Timolol—coronary artery disease	0.00014	0.000743	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Enalapril—coronary artery disease	0.000139	0.000741	CcSEcCtD
Ceftazidime—Abdominal pain—Pravastatin—coronary artery disease	0.000139	0.000741	CcSEcCtD
Ceftazidime—Body temperature increased—Pravastatin—coronary artery disease	0.000139	0.000741	CcSEcCtD
Ceftazidime—Hypotension—Losartan—coronary artery disease	0.000139	0.00074	CcSEcCtD
Ceftazidime—Dysgeusia—Lisinopril—coronary artery disease	0.000139	0.000739	CcSEcCtD
Ceftazidime—Dizziness—Clopidogrel—coronary artery disease	0.000139	0.000738	CcSEcCtD
Ceftazidime—Paraesthesia—Furosemide—coronary artery disease	0.000138	0.000737	CcSEcCtD
Ceftazidime—Pruritus—Simvastatin—coronary artery disease	0.000138	0.000733	CcSEcCtD
Ceftazidime—Dizziness—Lovastatin—coronary artery disease	0.000138	0.000733	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000137	0.000731	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000137	0.000729	CcSEcCtD
Ceftazidime—Diarrhoea—Eplerenone—coronary artery disease	0.000137	0.000728	CcSEcCtD
Ceftazidime—Urticaria—Trandolapril—coronary artery disease	0.000136	0.000723	CcSEcCtD
Ceftazidime—Pain—Perindopril—coronary artery disease	0.000136	0.000722	CcSEcCtD
Ceftazidime—Vomiting—Fenofibrate—coronary artery disease	0.000136	0.000722	CcSEcCtD
Ceftazidime—Hypersensitivity—Valsartan—coronary artery disease	0.000136	0.000721	CcSEcCtD
Ceftazidime—Convulsion—Ramipril—coronary artery disease	0.000135	0.000721	CcSEcCtD
Ceftazidime—Urticaria—Enalapril—coronary artery disease	0.000135	0.00072	CcSEcCtD
Ceftazidime—Body temperature increased—Trandolapril—coronary artery disease	0.000135	0.000719	CcSEcCtD
Ceftazidime—Abdominal pain—Trandolapril—coronary artery disease	0.000135	0.000719	CcSEcCtD
Ceftazidime—Dizziness—Ezetimibe—coronary artery disease	0.000135	0.000719	CcSEcCtD
Ceftazidime—Body temperature increased—Enalapril—coronary artery disease	0.000135	0.000716	CcSEcCtD
Ceftazidime—Abdominal pain—Enalapril—coronary artery disease	0.000135	0.000716	CcSEcCtD
Ceftazidime—Rash—Fenofibrate—coronary artery disease	0.000134	0.000716	CcSEcCtD
Ceftazidime—Dermatitis—Fenofibrate—coronary artery disease	0.000134	0.000715	CcSEcCtD
Ceftazidime—Headache—Fenofibrate—coronary artery disease	0.000134	0.000711	CcSEcCtD
Ceftazidime—Vision blurred—Lisinopril—coronary artery disease	0.000134	0.000711	CcSEcCtD
Ceftazidime—Paraesthesia—Losartan—coronary artery disease	0.000134	0.000711	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Captopril—coronary artery disease	0.000134	0.000711	CcSEcCtD
Ceftazidime—Urticaria—Telmisartan—coronary artery disease	0.000133	0.00071	CcSEcCtD
Ceftazidime—Vomiting—Clopidogrel—coronary artery disease	0.000133	0.000709	CcSEcCtD
Ceftazidime—Diarrhoea—Simvastatin—coronary artery disease	0.000133	0.000709	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000133	0.000708	CcSEcCtD
Ceftazidime—Tremor—Lisinopril—coronary artery disease	0.000133	0.000707	CcSEcCtD
Ceftazidime—Body temperature increased—Telmisartan—coronary artery disease	0.000133	0.000707	CcSEcCtD
Ceftazidime—Abdominal pain—Telmisartan—coronary artery disease	0.000133	0.000707	CcSEcCtD
Ceftazidime—Vomiting—Lovastatin—coronary artery disease	0.000132	0.000705	CcSEcCtD
Ceftazidime—Dizziness—Eplerenone—coronary artery disease	0.000132	0.000703	CcSEcCtD
Ceftazidime—Rash—Clopidogrel—coronary artery disease	0.000132	0.000703	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000132	0.000703	CcSEcCtD
Ceftazidime—Dermatitis—Clopidogrel—coronary artery disease	0.000132	0.000703	CcSEcCtD
Ceftazidime—Pain—Furosemide—coronary artery disease	0.000132	0.000702	CcSEcCtD
Ceftazidime—Hypersensitivity—Niacin—coronary artery disease	0.000132	0.000701	CcSEcCtD
Ceftazidime—Headache—Clopidogrel—coronary artery disease	0.000131	0.000699	CcSEcCtD
Ceftazidime—Rash—Lovastatin—coronary artery disease	0.000131	0.000699	CcSEcCtD
Ceftazidime—Dermatitis—Lovastatin—coronary artery disease	0.000131	0.000698	CcSEcCtD
Ceftazidime—Headache—Lovastatin—coronary artery disease	0.00013	0.000694	CcSEcCtD
Ceftazidime—Pruritus—Valsartan—coronary artery disease	0.00013	0.000693	CcSEcCtD
Ceftazidime—Vomiting—Ezetimibe—coronary artery disease	0.00013	0.000691	CcSEcCtD
Ceftazidime—Hypersensitivity—Pravastatin—coronary artery disease	0.00013	0.00069	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Perindopril—coronary artery disease	0.00013	0.00069	CcSEcCtD
Ceftazidime—Angioedema—Lisinopril—coronary artery disease	0.00013	0.000689	CcSEcCtD
Ceftazidime—Pruritus—Olmesartan—coronary artery disease	0.00013	0.000689	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000129	0.000687	CcSEcCtD
Ceftazidime—Abdominal pain—Captopril—coronary artery disease	0.000129	0.000687	CcSEcCtD
Ceftazidime—Body temperature increased—Captopril—coronary artery disease	0.000129	0.000687	CcSEcCtD
Ceftazidime—Dizziness—Simvastatin—coronary artery disease	0.000129	0.000685	CcSEcCtD
Ceftazidime—Rash—Ezetimibe—coronary artery disease	0.000129	0.000685	CcSEcCtD
Ceftazidime—Dermatitis—Ezetimibe—coronary artery disease	0.000129	0.000685	CcSEcCtD
Ceftazidime—Headache—Ezetimibe—coronary artery disease	0.000128	0.000681	CcSEcCtD
Ceftazidime—Anaphylactic shock—Ramipril—coronary artery disease	0.000128	0.000679	CcSEcCtD
Ceftazidime—Pain—Losartan—coronary artery disease	0.000127	0.000677	CcSEcCtD
Ceftazidime—Vomiting—Eplerenone—coronary artery disease	0.000127	0.000676	CcSEcCtD
Ceftazidime—Leukopenia—Lisinopril—coronary artery disease	0.000127	0.000675	CcSEcCtD
Ceftazidime—Nausea—Fenofibrate—coronary artery disease	0.000127	0.000674	CcSEcCtD
Ceftazidime—Pruritus—Niacin—coronary artery disease	0.000127	0.000673	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Furosemide—coronary artery disease	0.000126	0.000671	CcSEcCtD
Ceftazidime—Rash—Eplerenone—coronary artery disease	0.000126	0.000671	CcSEcCtD
Ceftazidime—Urticaria—Perindopril—coronary artery disease	0.000126	0.00067	CcSEcCtD
Ceftazidime—Hypersensitivity—Trandolapril—coronary artery disease	0.000126	0.00067	CcSEcCtD
Ceftazidime—Dermatitis—Eplerenone—coronary artery disease	0.000126	0.00067	CcSEcCtD
Ceftazidime—Diarrhoea—Valsartan—coronary artery disease	0.000126	0.00067	CcSEcCtD
Ceftazidime—Hypersensitivity—Enalapril—coronary artery disease	0.000125	0.000668	CcSEcCtD
Ceftazidime—Abdominal pain—Perindopril—coronary artery disease	0.000125	0.000667	CcSEcCtD
Ceftazidime—Body temperature increased—Perindopril—coronary artery disease	0.000125	0.000667	CcSEcCtD
Ceftazidime—Diarrhoea—Olmesartan—coronary artery disease	0.000125	0.000667	CcSEcCtD
Ceftazidime—Headache—Eplerenone—coronary artery disease	0.000125	0.000666	CcSEcCtD
Ceftazidime—Nervous system disorder—Ramipril—coronary artery disease	0.000125	0.000666	CcSEcCtD
Ceftazidime—Thrombocytopenia—Ramipril—coronary artery disease	0.000125	0.000665	CcSEcCtD
Ceftazidime—Anaphylactic shock—Timolol—coronary artery disease	0.000125	0.000664	CcSEcCtD
Ceftazidime—Pruritus—Pravastatin—coronary artery disease	0.000125	0.000663	CcSEcCtD
Ceftazidime—Nausea—Clopidogrel—coronary artery disease	0.000125	0.000663	CcSEcCtD
Ceftazidime—Skin disorder—Ramipril—coronary artery disease	0.000124	0.000659	CcSEcCtD
Ceftazidime—Vomiting—Simvastatin—coronary artery disease	0.000124	0.000659	CcSEcCtD
Ceftazidime—Hypersensitivity—Telmisartan—coronary artery disease	0.000124	0.000659	CcSEcCtD
Ceftazidime—Nausea—Lovastatin—coronary artery disease	0.000124	0.000658	CcSEcCtD
Ceftazidime—Rash—Simvastatin—coronary artery disease	0.000123	0.000654	CcSEcCtD
Ceftazidime—Dermatitis—Simvastatin—coronary artery disease	0.000123	0.000653	CcSEcCtD
Ceftazidime—Urticaria—Furosemide—coronary artery disease	0.000122	0.000652	CcSEcCtD
Ceftazidime—Diarrhoea—Niacin—coronary artery disease	0.000122	0.000651	CcSEcCtD
Ceftazidime—Nervous system disorder—Timolol—coronary artery disease	0.000122	0.000651	CcSEcCtD
Ceftazidime—Headache—Simvastatin—coronary artery disease	0.000122	0.000649	CcSEcCtD
Ceftazidime—Abdominal pain—Furosemide—coronary artery disease	0.000122	0.000649	CcSEcCtD
Ceftazidime—Body temperature increased—Furosemide—coronary artery disease	0.000122	0.000649	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Losartan—coronary artery disease	0.000122	0.000647	CcSEcCtD
Ceftazidime—Dizziness—Valsartan—coronary artery disease	0.000122	0.000647	CcSEcCtD
Ceftazidime—Nausea—Ezetimibe—coronary artery disease	0.000121	0.000646	CcSEcCtD
Ceftazidime—Skin disorder—Timolol—coronary artery disease	0.000121	0.000645	CcSEcCtD
Ceftazidime—Dizziness—Olmesartan—coronary artery disease	0.000121	0.000644	CcSEcCtD
Ceftazidime—Pruritus—Trandolapril—coronary artery disease	0.000121	0.000644	CcSEcCtD
Ceftazidime—Pruritus—Enalapril—coronary artery disease	0.000121	0.000641	CcSEcCtD
Ceftazidime—Diarrhoea—Pravastatin—coronary artery disease	0.00012	0.000641	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.00012	0.000638	CcSEcCtD
Ceftazidime—Hypotension—Ramipril—coronary artery disease	0.000119	0.000634	CcSEcCtD
Ceftazidime—Pruritus—Telmisartan—coronary artery disease	0.000119	0.000632	CcSEcCtD
Ceftazidime—Nausea—Eplerenone—coronary artery disease	0.000119	0.000632	CcSEcCtD
Ceftazidime—Dizziness—Niacin—coronary artery disease	0.000118	0.000629	CcSEcCtD
Ceftazidime—Urticaria—Losartan—coronary artery disease	0.000118	0.000629	CcSEcCtD
Ceftazidime—Body temperature increased—Losartan—coronary artery disease	0.000118	0.000626	CcSEcCtD
Ceftazidime—Abdominal pain—Losartan—coronary artery disease	0.000118	0.000626	CcSEcCtD
Ceftazidime—Diarrhoea—Trandolapril—coronary artery disease	0.000117	0.000623	CcSEcCtD
Ceftazidime—Vomiting—Valsartan—coronary artery disease	0.000117	0.000622	CcSEcCtD
Ceftazidime—Diarrhoea—Enalapril—coronary artery disease	0.000117	0.00062	CcSEcCtD
Ceftazidime—Hypotension—Timolol—coronary artery disease	0.000117	0.00062	CcSEcCtD
Ceftazidime—Dizziness—Pravastatin—coronary artery disease	0.000116	0.00062	CcSEcCtD
Ceftazidime—Vomiting—Olmesartan—coronary artery disease	0.000116	0.000619	CcSEcCtD
Ceftazidime—Rash—Valsartan—coronary artery disease	0.000116	0.000617	CcSEcCtD
Ceftazidime—Dermatitis—Valsartan—coronary artery disease	0.000116	0.000617	CcSEcCtD
Ceftazidime—Nausea—Simvastatin—coronary artery disease	0.000116	0.000616	CcSEcCtD
Ceftazidime—Anaphylactic shock—Lisinopril—coronary artery disease	0.000116	0.000616	CcSEcCtD
Ceftazidime—Pruritus—Captopril—coronary artery disease	0.000116	0.000615	CcSEcCtD
Ceftazidime—Rash—Olmesartan—coronary artery disease	0.000115	0.000614	CcSEcCtD
Ceftazidime—Dermatitis—Olmesartan—coronary artery disease	0.000115	0.000614	CcSEcCtD
Ceftazidime—Headache—Valsartan—coronary artery disease	0.000115	0.000613	CcSEcCtD
Ceftazidime—Diarrhoea—Telmisartan—coronary artery disease	0.000115	0.000612	CcSEcCtD
Ceftazidime—Headache—Olmesartan—coronary artery disease	0.000115	0.00061	CcSEcCtD
Ceftazidime—Paraesthesia—Ramipril—coronary artery disease	0.000115	0.00061	CcSEcCtD
Ceftazidime—Vomiting—Niacin—coronary artery disease	0.000114	0.000605	CcSEcCtD
Ceftazidime—Hypersensitivity—Furosemide—coronary artery disease	0.000114	0.000604	CcSEcCtD
Ceftazidime—Thrombocytopenia—Lisinopril—coronary artery disease	0.000113	0.000603	CcSEcCtD
Ceftazidime—Dizziness—Trandolapril—coronary artery disease	0.000113	0.000602	CcSEcCtD
Ceftazidime—Rash—Niacin—coronary artery disease	0.000113	0.0006	CcSEcCtD
Ceftazidime—Dermatitis—Niacin—coronary artery disease	0.000113	0.0006	CcSEcCtD
Ceftazidime—Dizziness—Enalapril—coronary artery disease	0.000113	0.000599	CcSEcCtD
Ceftazidime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A6—coronary artery disease	0.000112	0.0254	CbGpPWpGaD
Ceftazidime—Skin disorder—Lisinopril—coronary artery disease	0.000112	0.000598	CcSEcCtD
Ceftazidime—Pruritus—Perindopril—coronary artery disease	0.000112	0.000597	CcSEcCtD
Ceftazidime—Headache—Niacin—coronary artery disease	0.000112	0.000596	CcSEcCtD
Ceftazidime—Paraesthesia—Timolol—coronary artery disease	0.000112	0.000596	CcSEcCtD
Ceftazidime—Vomiting—Pravastatin—coronary artery disease	0.000112	0.000596	CcSEcCtD
Ceftazidime—Diarrhoea—Captopril—coronary artery disease	0.000112	0.000595	CcSEcCtD
Ceftazidime—Dizziness—Telmisartan—coronary artery disease	0.000111	0.000591	CcSEcCtD
Ceftazidime—Rash—Pravastatin—coronary artery disease	0.000111	0.000591	CcSEcCtD
Ceftazidime—Dermatitis—Pravastatin—coronary artery disease	0.000111	0.00059	CcSEcCtD
Ceftazidime—Headache—Pravastatin—coronary artery disease	0.00011	0.000587	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Ramipril—coronary artery disease	0.00011	0.000586	CcSEcCtD
Ceftazidime—Hypersensitivity—Losartan—coronary artery disease	0.00011	0.000583	CcSEcCtD
Ceftazidime—Nausea—Valsartan—coronary artery disease	0.000109	0.000581	CcSEcCtD
Ceftazidime—Pruritus—Furosemide—coronary artery disease	0.000109	0.00058	CcSEcCtD
Ceftazidime—Nausea—Olmesartan—coronary artery disease	0.000109	0.000579	CcSEcCtD
Ceftazidime—Vomiting—Trandolapril—coronary artery disease	0.000109	0.000579	CcSEcCtD
Ceftazidime—Diarrhoea—Perindopril—coronary artery disease	0.000109	0.000577	CcSEcCtD
Ceftazidime—Vomiting—Enalapril—coronary artery disease	0.000108	0.000576	CcSEcCtD
Ceftazidime—Hypotension—Lisinopril—coronary artery disease	0.000108	0.000575	CcSEcCtD
Ceftazidime—Dizziness—Captopril—coronary artery disease	0.000108	0.000575	CcSEcCtD
Ceftazidime—Rash—Trandolapril—coronary artery disease	0.000108	0.000574	CcSEcCtD
Ceftazidime—Dermatitis—Trandolapril—coronary artery disease	0.000108	0.000573	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Timolol—coronary artery disease	0.000108	0.000573	CcSEcCtD
Ceftazidime—Rash—Enalapril—coronary artery disease	0.000107	0.000571	CcSEcCtD
Ceftazidime—Dermatitis—Enalapril—coronary artery disease	0.000107	0.000571	CcSEcCtD
Ceftazidime—Headache—Trandolapril—coronary artery disease	0.000107	0.00057	CcSEcCtD
Ceftazidime—Vomiting—Telmisartan—coronary artery disease	0.000107	0.000568	CcSEcCtD
Ceftazidime—Headache—Enalapril—coronary artery disease	0.000107	0.000568	CcSEcCtD
Ceftazidime—Pain—Timolol—coronary artery disease	0.000107	0.000567	CcSEcCtD
Ceftazidime—Nausea—Niacin—coronary artery disease	0.000106	0.000565	CcSEcCtD
Ceftazidime—Rash—Telmisartan—coronary artery disease	0.000106	0.000564	CcSEcCtD
Ceftazidime—Dermatitis—Telmisartan—coronary artery disease	0.000106	0.000563	CcSEcCtD
Ceftazidime—Diarrhoea—Furosemide—coronary artery disease	0.000106	0.000561	CcSEcCtD
Ceftazidime—Pruritus—Losartan—coronary artery disease	0.000105	0.00056	CcSEcCtD
Ceftazidime—Headache—Telmisartan—coronary artery disease	0.000105	0.00056	CcSEcCtD
Ceftazidime—Dizziness—Perindopril—coronary artery disease	0.000105	0.000558	CcSEcCtD
Ceftazidime—Nausea—Pravastatin—coronary artery disease	0.000105	0.000557	CcSEcCtD
Ceftazidime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC6A6—coronary artery disease	0.000104	0.0236	CbGpPWpGaD
Ceftazidime—Gastrointestinal pain—Ramipril—coronary artery disease	0.000104	0.000555	CcSEcCtD
Ceftazidime—Paraesthesia—Lisinopril—coronary artery disease	0.000104	0.000553	CcSEcCtD
Ceftazidime—Vomiting—Captopril—coronary artery disease	0.000104	0.000553	CcSEcCtD
Ceftazidime—Rash—Captopril—coronary artery disease	0.000103	0.000548	CcSEcCtD
Ceftazidime—Dermatitis—Captopril—coronary artery disease	0.000103	0.000548	CcSEcCtD
Ceftazidime—Headache—Captopril—coronary artery disease	0.000102	0.000545	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Timolol—coronary artery disease	0.000102	0.000543	CcSEcCtD
Ceftazidime—Dizziness—Furosemide—coronary artery disease	0.000102	0.000543	CcSEcCtD
Ceftazidime—Diarrhoea—Losartan—coronary artery disease	0.000102	0.000542	CcSEcCtD
Ceftazidime—Nausea—Trandolapril—coronary artery disease	0.000102	0.000541	CcSEcCtD
Ceftazidime—Urticaria—Ramipril—coronary artery disease	0.000101	0.000539	CcSEcCtD
Ceftazidime—Nausea—Enalapril—coronary artery disease	0.000101	0.000538	CcSEcCtD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A6—coronary artery disease	0.000101	0.0228	CbGpPWpGaD
Ceftazidime—Vomiting—Perindopril—coronary artery disease	0.000101	0.000537	CcSEcCtD
Ceftazidime—Abdominal pain—Ramipril—coronary artery disease	0.000101	0.000537	CcSEcCtD
Ceftazidime—Body temperature increased—Ramipril—coronary artery disease	0.000101	0.000537	CcSEcCtD
Ceftazidime—Rash—Perindopril—coronary artery disease	0.0001	0.000532	CcSEcCtD
Ceftazidime—Dermatitis—Perindopril—coronary artery disease	9.99e-05	0.000532	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Lisinopril—coronary artery disease	9.99e-05	0.000531	CcSEcCtD
Ceftazidime—Nausea—Telmisartan—coronary artery disease	9.98e-05	0.000531	CcSEcCtD
Ceftazidime—Headache—Perindopril—coronary artery disease	9.94e-05	0.000529	CcSEcCtD
Ceftazidime—Urticaria—Timolol—coronary artery disease	9.91e-05	0.000527	CcSEcCtD
Ceftazidime—Pain—Lisinopril—coronary artery disease	9.89e-05	0.000526	CcSEcCtD
Ceftazidime—Abdominal pain—Timolol—coronary artery disease	9.86e-05	0.000525	CcSEcCtD
Ceftazidime—Body temperature increased—Timolol—coronary artery disease	9.86e-05	0.000525	CcSEcCtD
Ceftazidime—Dizziness—Losartan—coronary artery disease	9.84e-05	0.000523	CcSEcCtD
Ceftazidime—Vomiting—Furosemide—coronary artery disease	9.8e-05	0.000522	CcSEcCtD
Ceftazidime—Rash—Furosemide—coronary artery disease	9.72e-05	0.000517	CcSEcCtD
Ceftazidime—Dermatitis—Furosemide—coronary artery disease	9.71e-05	0.000517	CcSEcCtD
Ceftazidime—Nausea—Captopril—coronary artery disease	9.7e-05	0.000516	CcSEcCtD
Ceftazidime—Headache—Furosemide—coronary artery disease	9.66e-05	0.000514	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Lisinopril—coronary artery disease	9.46e-05	0.000503	CcSEcCtD
Ceftazidime—Vomiting—Losartan—coronary artery disease	9.46e-05	0.000503	CcSEcCtD
Ceftazidime—Nausea—Perindopril—coronary artery disease	9.42e-05	0.000501	CcSEcCtD
Ceftazidime—Hypersensitivity—Ramipril—coronary artery disease	9.4e-05	0.0005	CcSEcCtD
Ceftazidime—Rash—Losartan—coronary artery disease	9.38e-05	0.000499	CcSEcCtD
Ceftazidime—Dermatitis—Losartan—coronary artery disease	9.37e-05	0.000499	CcSEcCtD
Ceftazidime—Headache—Losartan—coronary artery disease	9.32e-05	0.000496	CcSEcCtD
Ceftazidime—Urticaria—Lisinopril—coronary artery disease	9.19e-05	0.000489	CcSEcCtD
Ceftazidime—Hypersensitivity—Timolol—coronary artery disease	9.19e-05	0.000489	CcSEcCtD
Ceftazidime—Nausea—Furosemide—coronary artery disease	9.16e-05	0.000487	CcSEcCtD
Ceftazidime—Body temperature increased—Lisinopril—coronary artery disease	9.15e-05	0.000487	CcSEcCtD
Ceftazidime—Abdominal pain—Lisinopril—coronary artery disease	9.15e-05	0.000487	CcSEcCtD
Ceftazidime—Pruritus—Ramipril—coronary artery disease	9.03e-05	0.00048	CcSEcCtD
Ceftazidime—Nausea—Losartan—coronary artery disease	8.84e-05	0.00047	CcSEcCtD
Ceftazidime—Pruritus—Timolol—coronary artery disease	8.82e-05	0.000469	CcSEcCtD
Ceftazidime—Diarrhoea—Ramipril—coronary artery disease	8.73e-05	0.000464	CcSEcCtD
Ceftazidime—Diarrhoea—Timolol—coronary artery disease	8.53e-05	0.000454	CcSEcCtD
Ceftazidime—Hypersensitivity—Lisinopril—coronary artery disease	8.52e-05	0.000454	CcSEcCtD
Ceftazidime—Dizziness—Ramipril—coronary artery disease	8.44e-05	0.000449	CcSEcCtD
Ceftazidime—Dizziness—Timolol—coronary artery disease	8.25e-05	0.000439	CcSEcCtD
Ceftazidime—Pruritus—Lisinopril—coronary artery disease	8.19e-05	0.000436	CcSEcCtD
Ceftazidime—Vomiting—Ramipril—coronary artery disease	8.11e-05	0.000432	CcSEcCtD
Ceftazidime—Rash—Ramipril—coronary artery disease	8.04e-05	0.000428	CcSEcCtD
Ceftazidime—Dermatitis—Ramipril—coronary artery disease	8.04e-05	0.000428	CcSEcCtD
Ceftazidime—Headache—Ramipril—coronary artery disease	7.99e-05	0.000425	CcSEcCtD
Ceftazidime—Vomiting—Timolol—coronary artery disease	7.93e-05	0.000422	CcSEcCtD
Ceftazidime—Diarrhoea—Lisinopril—coronary artery disease	7.92e-05	0.000421	CcSEcCtD
Ceftazidime—Rash—Timolol—coronary artery disease	7.86e-05	0.000418	CcSEcCtD
Ceftazidime—Dermatitis—Timolol—coronary artery disease	7.86e-05	0.000418	CcSEcCtD
Ceftazidime—Headache—Timolol—coronary artery disease	7.81e-05	0.000416	CcSEcCtD
Ceftazidime—Dizziness—Lisinopril—coronary artery disease	7.65e-05	0.000407	CcSEcCtD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A6—coronary artery disease	7.62e-05	0.0172	CbGpPWpGaD
Ceftazidime—Nausea—Ramipril—coronary artery disease	7.58e-05	0.000403	CcSEcCtD
Ceftazidime—Nausea—Timolol—coronary artery disease	7.41e-05	0.000394	CcSEcCtD
Ceftazidime—Vomiting—Lisinopril—coronary artery disease	7.36e-05	0.000391	CcSEcCtD
Ceftazidime—Rash—Lisinopril—coronary artery disease	7.29e-05	0.000388	CcSEcCtD
Ceftazidime—Dermatitis—Lisinopril—coronary artery disease	7.29e-05	0.000388	CcSEcCtD
Ceftazidime—Headache—Lisinopril—coronary artery disease	7.25e-05	0.000386	CcSEcCtD
Ceftazidime—Nausea—Lisinopril—coronary artery disease	6.87e-05	0.000366	CcSEcCtD
Ceftazidime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—coronary artery disease	6.68e-05	0.0151	CbGpPWpGaD
Ceftazidime—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—coronary artery disease	6.5e-05	0.0147	CbGpPWpGaD
Ceftazidime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC8A1—coronary artery disease	6.2e-05	0.014	CbGpPWpGaD
Ceftazidime—Ceftriaxone—ALB—coronary artery disease	5.88e-05	0.0962	CrCbGaD
Ceftazidime—Cefalotin—ALB—coronary artery disease	5.15e-05	0.0843	CrCbGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	5.02e-05	0.0113	CbGpPWpGaD
Ceftazidime—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—coronary artery disease	5.01e-05	0.0113	CbGpPWpGaD
Ceftazidime—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—coronary artery disease	4.91e-05	0.0111	CbGpPWpGaD
Ceftazidime—Cephalexin—ALB—coronary artery disease	4.68e-05	0.0766	CrCbGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	4.66e-05	0.0105	CbGpPWpGaD
Ceftazidime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—coronary artery disease	4.65e-05	0.0105	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	4.58e-05	0.0104	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—HK2—coronary artery disease	3.81e-05	0.0086	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	3.65e-05	0.00825	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—HK2—coronary artery disease	3.53e-05	0.00798	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—HK2—coronary artery disease	3.47e-05	0.00785	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC6A6—coronary artery disease	3.46e-05	0.00782	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	3.39e-05	0.00765	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	3.33e-05	0.00753	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	3.24e-05	0.00731	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	3e-05	0.00679	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	3e-05	0.00678	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	2.99e-05	0.00675	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—HK1—coronary artery disease	2.99e-05	0.00675	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	2.95e-05	0.00667	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—FXYD1—coronary artery disease	2.79e-05	0.00629	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—HK1—coronary artery disease	2.77e-05	0.00626	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	2.77e-05	0.00626	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—FXYD1—coronary artery disease	2.74e-05	0.00619	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—HK1—coronary artery disease	2.73e-05	0.00616	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	2.73e-05	0.00616	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	2.68e-05	0.00605	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—CFTR—coronary artery disease	2.68e-05	0.00605	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—HK2—coronary artery disease	2.62e-05	0.00593	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	2.55e-05	0.00577	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	2.51e-05	0.00568	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	2.48e-05	0.00561	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—CFTR—coronary artery disease	2.48e-05	0.00561	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—CFTR—coronary artery disease	2.44e-05	0.00552	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	2.44e-05	0.00552	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	2.37e-05	0.00535	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	2.33e-05	0.00526	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	2.24e-05	0.00505	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	2.23e-05	0.00504	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—COX5B—coronary artery disease	2.14e-05	0.00483	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—RYR2—coronary artery disease	2.14e-05	0.00483	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—PLN—coronary artery disease	2.08e-05	0.0047	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	2.08e-05	0.00469	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—FXYD1—coronary artery disease	2.07e-05	0.00467	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—HK1—coronary artery disease	2.06e-05	0.00465	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	2.06e-05	0.00465	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	2.04e-05	0.00461	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—RYR2—coronary artery disease	1.99e-05	0.00449	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—COX5B—coronary artery disease	1.99e-05	0.00449	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—RYR2—coronary artery disease	1.95e-05	0.00441	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—COX5B—coronary artery disease	1.95e-05	0.00441	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—HK2—coronary artery disease	1.93e-05	0.00437	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—PLN—coronary artery disease	1.93e-05	0.00436	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—PLN—coronary artery disease	1.9e-05	0.00429	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	1.85e-05	0.00419	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	1.85e-05	0.00419	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	1.84e-05	0.00416	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—CFTR—coronary artery disease	1.84e-05	0.00416	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—HK2—coronary artery disease	1.8e-05	0.00406	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—HK2—coronary artery disease	1.77e-05	0.00399	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	1.76e-05	0.00397	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	1.72e-05	0.00389	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	1.72e-05	0.00389	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ATP4A—coronary artery disease	1.69e-05	0.00382	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	1.69e-05	0.00382	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	1.64e-05	0.00372	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	1.64e-05	0.00372	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	1.54e-05	0.00348	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	1.53e-05	0.00345	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	1.53e-05	0.00345	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	1.52e-05	0.00343	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	1.52e-05	0.00343	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—HK1—coronary artery disease	1.52e-05	0.00343	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	1.5e-05	0.00339	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	1.5e-05	0.00339	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—COX5B—coronary artery disease	1.47e-05	0.00333	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—RYR2—coronary artery disease	1.47e-05	0.00333	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—PLN—coronary artery disease	1.43e-05	0.00324	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	1.41e-05	0.00318	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—HK1—coronary artery disease	1.41e-05	0.00318	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	1.41e-05	0.00318	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ABCG5—coronary artery disease	1.39e-05	0.00313	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	1.39e-05	0.00313	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—HK1—coronary artery disease	1.39e-05	0.00313	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—HK2—coronary artery disease	1.33e-05	0.00301	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	1.28e-05	0.00289	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ATP4A—coronary artery disease	1.28e-05	0.00289	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	1.16e-05	0.00263	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	1.14e-05	0.00257	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	1.13e-05	0.00256	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	1.13e-05	0.00256	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—CETP—coronary artery disease	1.12e-05	0.00254	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	1.08e-05	0.00244	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—TFRC—coronary artery disease	1.07e-05	0.00241	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	1.06e-05	0.0024	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	1.05e-05	0.00238	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ABCG5—coronary artery disease	1.05e-05	0.00236	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—HK1—coronary artery disease	1.05e-05	0.00236	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	1.05e-05	0.00236	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—CETP—coronary artery disease	1.04e-05	0.00236	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	1.04e-05	0.00234	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—CETP—coronary artery disease	1.03e-05	0.00232	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—PLAT—coronary artery disease	9.9e-06	0.00224	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—TFRC—coronary artery disease	9.89e-06	0.00223	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—TFRC—coronary artery disease	9.72e-06	0.0022	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—PLAT—coronary artery disease	9.19e-06	0.00208	CbGpPWpGaD
Ceftazidime—SLC15A2—SLC-mediated transmembrane transport—ALB—coronary artery disease	9.18e-06	0.00207	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—PLAT—coronary artery disease	9.04e-06	0.00204	CbGpPWpGaD
Ceftazidime—SLC15A1—SLC-mediated transmembrane transport—ALB—coronary artery disease	8.52e-06	0.00193	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—PLG—coronary artery disease	8.42e-06	0.0019	CbGpPWpGaD
Ceftazidime—SLC22A5—SLC-mediated transmembrane transport—ALB—coronary artery disease	8.38e-06	0.00189	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	8.02e-06	0.00181	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	7.83e-06	0.00177	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—PLG—coronary artery disease	7.81e-06	0.00177	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	7.77e-06	0.00176	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—CETP—coronary artery disease	7.74e-06	0.00175	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—PLG—coronary artery disease	7.69e-06	0.00174	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—APOB—coronary artery disease	7.44e-06	0.00168	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—TFRC—coronary artery disease	7.34e-06	0.00166	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	7.21e-06	0.00163	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—HMOX1—coronary artery disease	7.09e-06	0.0016	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—APOB—coronary artery disease	6.91e-06	0.00156	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—PLAT—coronary artery disease	6.82e-06	0.00154	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—APOB—coronary artery disease	6.79e-06	0.00153	CbGpPWpGaD
Ceftazidime—SLC22A6—SLC-mediated transmembrane transport—ALB—coronary artery disease	6.33e-06	0.00143	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	5.89e-06	0.00133	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—PLG—coronary artery disease	5.8e-06	0.00131	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—APOA1—coronary artery disease	5.47e-06	0.00123	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—APOA1—coronary artery disease	5.38e-06	0.00121	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—HMOX1—coronary artery disease	5.35e-06	0.00121	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—APOB—coronary artery disease	5.13e-06	0.00116	CbGpPWpGaD
Ceftazidime—SLC15A2—Transmembrane transport of small molecules—ALB—coronary artery disease	4.67e-06	0.00105	CbGpPWpGaD
Ceftazidime—SLC15A1—Transmembrane transport of small molecules—ALB—coronary artery disease	4.33e-06	0.000978	CbGpPWpGaD
Ceftazidime—SLC22A5—Transmembrane transport of small molecules—ALB—coronary artery disease	4.26e-06	0.000962	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—APOA1—coronary artery disease	4.06e-06	0.000917	CbGpPWpGaD
Ceftazidime—SLC22A6—Transmembrane transport of small molecules—ALB—coronary artery disease	3.21e-06	0.000726	CbGpPWpGaD
